Citation Impact
Citing Papers
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis
2014 StandoutNobel
Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis
2016
Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosis
2017
Sonographic fatty liver, overweight and ischemic heart disease
2005
Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States
2012
ADAPT: An Algorithm Incorporating PRO‐C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis
2018
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
2016
Review article: the current management of acute liver failure
2009
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study
2018
NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States
2002
Effects of Liver Biopsy Sample Length and Number of Readings on Sampling Variability in Nonalcoholic Fatty Liver Disease
2008
Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non‐alcoholic fatty liver disease
2006
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
2010 Standout
Atorvastatin and Antioxidants for the Treatment of Nonalcoholic Fatty Liver Disease: The St Francis Heart Study Randomized Clinical Trial
2010
Confounding factors of non-invasive tests for nonalcoholic fatty liver disease
2020
Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver
2004
Thiazolidinediones
2004 Standout
Increased Risk of CKD among Type 2 Diabetics with Nonalcoholic Fatty Liver Disease
2008
HFE mutations, hepatic iron, and fibrosis: Ethnic-specific association of NASH with C282Y but not with fibrotic severity
2002
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity
2017
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
Recent concepts in non‐alcoholic fatty liver disease
2005
Nonalcoholic Fatty Liver Disease in Primary Aldosteronism: A Pilot Study
2009
Prevalence and associated factors of non‐alcoholic fatty liver disease in patients with type‐2 diabetes mellitus
2008
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
2004
Clinical assessment for high‐risk patients with non‐alcoholic fatty liver disease in primary care and diabetology practices
2020
Impact of non‐alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes
2009
Pathologic features associated with fibrosis in nonalcoholic fatty liver disease
2004
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients
2007
Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease
2016
Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis
2002
Liver fibrosis
2005 Standout
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus
2020
NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral Fat in Men
2008
Alanine aminotransferase predicts coronary heart disease events: A 10-year follow-up of the Hoorn Study
2006
NAFLD: Reporting Histologic Findings in Clinical Practice
2020
Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States
2012
Nonalcoholic fatty liver disease
2002
Visceral adipose tissue area is an independent risk factor for hepatic steatosis
2007
Mortality From Chronic Liver Diseases in Diabetes
2014
Endpoints and clinical trial design for nonalcoholic steatohepatitis
2011
The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease
2004
Liver transplantation and non-alcoholic fatty liver disease
2014
The Prevalence of Metabolic Syndrome In Non-alcoholic Fatty Liver Disease; A Population-Based Study
2016
Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study
2010
Light and Moderate Alcohol Consumption Significantly Reduces the Prevalence of Fatty Liver in the Japanese Male Population
2009
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
The metabolic syndrome
2010 Standout
New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD)
2009
Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease
2011
Nonalcoholic Fatty Liver Disease
2002 Standout
Prevalence of non‐alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults
2005
Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol
2016
Effect of exercise on the development of new fatty liver and the resolution of existing fatty liver
2016
NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States
2002
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
The Natural History of Non-Alcoholic Fatty Liver Disease
2010
A position statement on NAFLD/NASH based on the EASL 2009 special conference
2010
Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive
2008
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Natural history of chronic hepatitis C
2002
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease
2010
Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications
2010
New Imaging Techniques for Non-Alcoholic Steatohepatitis
2009
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
2004 Standout
Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients
2002
Incidence of non-alcoholic fatty liver disease in Hong Kong: A population study with paired proton-magnetic resonance spectroscopy
2014
Are Women With Polycystic Ovarian Syndrome at a High Risk of Non-Alcoholic Fatty Liver Disease? A Meta-Analysis
2014
Persistent alanine aminotransferase elevation among the general Iranian population: Prevalence and causes
2008
Pathological Features of Fatty Liver Disease
2014
Mechanisms and disease consequences of nonalcoholic fatty liver disease
2021
Non-alcoholic fatty liver disease: The mist gradually clears
2008
Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension
2014
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
2005 Standout
Role of Radiologic Modalities in the Management of Non-alcoholic Steatohepatitis
2007
Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality
2016
Update on Nonalcoholic Fatty Liver Disease
2002
Prolonged n‐3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non‐alcoholic fatty liver disease: a pilot study
2006
Effects of iron overload on chronic metabolic diseases
2014
Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan
2006
Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 protein
2010
Omega-3 Fatty Acids Therapy in Children with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial
2015
Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease
2014
Metabolic Syndrome Is Associated with Greater Histologic Severity, Higher Carbohydrate, and Lower Fat Diet in Patients with NAFLD
2006
Multimorbidity and polypharmacy in diabetic patients with NAFLD
2017
Imaging-based Quantification of Hepatic Fat: Methods and Clinical Applications
2009
AGA technical review on nonalcoholic fatty liver disease
2002
From NAFLD in clinical practice to answers from guidelines
2013
Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease
2014
Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
2013
Liver fibrosis in overweight patients
2000
Diabetic Retinopathy
2012 Standout
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Global cancer statistics
2011 Standout
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
2020
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise
2018
Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects
2001
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
The metabolic syndrome
2005 Standout
Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies
2020
Non-alcoholic fatty liver disease
2021 Standout
High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: A potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis
2001
Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain
2009
Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography
2011
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
2007
Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis
2001
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
2010
Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
2009
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
2011 Standout
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
2010
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
2008
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
Prevalence of and Risk Factors for Nonalcoholic Fatty Liver Disease: The Dionysos Nutrition and Liver Study * #
2005
Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes
2015
Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma
2002
Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)
2018
Left Ventricular Dysfunction in Obese Children and Adolescents With Nonalcoholic Fatty Liver Disease
2013
Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men
2008
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
2010
Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016
2016
Impact of current transplantation practices on the changing epidemiology of infections in transplant recipients
2003
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
2013
Non-alcoholic fatty liver disease and liver transplantation
2016
American Gastroenterological Association Technical Review on the Management of Hepatitis C
2006
Liver Transplantation for Nonalcoholic Steatohepatitis
2012
Dietary habits and nutrient intake in non-alcoholic steatohepatitis
2006
Magnetic resonance imaging and spectroscopy for monitoring liver steatosis
2008
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: A review of 589 consecutive liver biopsies in a single center
2007
Fat, diabetes, and liver injury in chronic hepatitis C
2004
Non-alcoholic fatty liver disease: current concepts and management strategies
2006
Apnoeic–hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis
2008
Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients
2001
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
2017
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
NASH and HCC
2009
Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality
2011
Radiologic evaluation of nonalcoholic fatty liver disease
2014
Are there Predictive Factors of Severe Liver Fibrosis in Morbidly Obese Patients with Non-alcoholic Steatohepatitis?
2001
Non‐alcoholic fatty liver disease – a common and benign finding in octogenarian patients
2004
Nonalcoholic steatohepatitis
2004
Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆
1999 Standout
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
2012
Independent Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in the US Population
2012
Vitamin E and changes in serum alanine aminotransferase levels in patients with non‐alcoholic steatohepatitis
2013
Donor evaluation and hepatectomy for living-donor liver transplantation
2008
NAFLD in Asia—as common and important as in the West
2013
Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome
2003
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
2019
Nonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort Study
2010
Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in korean men: 5-year prospective cohort study
2012
Noninvasive Differentiation of Simple Steatosis and Steatohepatitis by Using Gadoxetic Acid–enhanced MR Imaging in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study
2014
Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
2011
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Prognostic Value of Controlled Attenuation Parameter by Transient Elastography
2017
Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease
2008
Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease
2014
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study
2006
Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome
2008
In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not
2012
Pathologic Assessment of Non-alcoholic Fatty Liver Disease
2007
Subacute liver failure in obese women
2002
Extrahepatic complications of nonalcoholic fatty liver disease
2013
Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
2009
Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance
2009
Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease
2003
Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort
2021
Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease
2011
Methods for assessing intrahepatic fat content and steatosis
2009
Cohort Study of Non-alcoholic Fatty Liver Disease, NAFLD fibrosis score, and the Risk of Incident Diabetes in a Korean population
2013
Nonalcoholic steatohepatitis and increased risk of chronic kidney disease
2010
Clinical trial: insulin‐sensitizing agents may reduce consequences of insulin resistance in individuals with non‐alcoholic steatohepatitis
2008
Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patients
2020
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
2014
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
2006 Standout
Prevalence of primary non‐alcoholic fatty liver disease in a population‐based study and its association with biochemical and anthropometric measures
2006
Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease
2004
Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study
2009
Hepatocellular Carcinoma
2011 Standout
Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice
2007 StandoutNobel
Diagnosis of fatty liver disease
2003
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
2014
Increased risk of cardiovascular disease and chronic kidney disease in NAFLD
2012
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
NAFLD: A multisystem disease
2015 Standout
Insulin resistance–associated hepatic iron overload
1999
Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States
2021
Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis
2016
Fatty liver is an independent predictor of early carotid atherosclerosis
2016
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients
2010
Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease
2005
Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy
2011
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
2014
Non‐alcoholic steatohepatitis: What is it, and why is it important in the Asia–Pacific region?
2003
Prevalence and risk factors for non‐alcoholic fatty liver disease among adults in an urban Sri Lankan population
2009
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question
2007
Comparison of Hepatocellular Carcinoma Patients With Alcoholic Liver Disease and Nonalcoholic Steatohepatitis
2004
Predictors of Nonalcoholic Steatohepatitis and Advanced Fibrosis in Morbidly Obese Patients
2005
Nonalcoholic Fatty Liver Disease Among HIV-Infected Persons
2009
Heritability of non‐alcoholic fatty liver disease and association with abnormal vascular parameters: A twin study
2012
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Evaluation of Liver Fibrosis: A Concise Review
2004
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Influence of non‐alcoholic fatty liver disease on the development of diabetes mellitus
2012
Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
2013
Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy
2011
A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease
2015
Non‐invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE
2015
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Lower levels of insulin‐like growth factor‐1 standard deviation score are associated with histological severity of non‐alcoholic fatty liver disease
2014
Approach to the Pathogenesis and Treatment of Nonalcoholic Steatohepatitis
2004
The preventive effect of sustained physical activity on incident nonalcoholic fatty liver disease
2016
Ectopic Fat, Insulin Resistance, and Nonalcoholic Fatty Liver Disease
2014
Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations
2008
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
2016
Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the U.S.
2019
Resolution of Fatty Liver and Risk of Incident Diabetes
2013
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
2013
Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
2016
A randomized controlled trial on the effectiveness of 8-week high-intensity interval exercise on intrahepatic triglycerides, visceral lipids, and health-related quality of life in diabetic obese patients with nonalcoholic fatty liver disease
2019
Non-alcoholic Fatty Liver Disease and Chronic Kidney Disease in Koreans Aged 50 Years or Older
2013
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
2015
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials
2013
The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
2005
Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis
2005
Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients
2007
Noninvasive imaging methods to determine severity of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
2016
Pathogenesis of Non-alcoholic Steatohepatitis: Human Data
2007
The Association Between Diabetes and Hepatocellular Carcinoma: A Systematic Review of Epidemiologic Evidence
2006
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
2014 Standout
Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Cardiovascular Events in Type 2 Diabetic Patients
2007
Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessment
2017
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan
2020
Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
2009
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Controlled attenuation parameter for the diagnosis of steatosis in non‐alcoholic fatty liver disease
2015
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Non‐alcoholic fatty liver disease in diabetics – prevalence and predictive factors in a multiracial hospital clinic population in M alaysia
2013
Iron-Deficiency Anemia
2015 Standout
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
2015
Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease in an Adult Population of Taiwan: Metabolic Significance of Nonalcoholic Fatty Liver Disease in Nonobese Adults
2006
Prevalence of Nonalcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome
2007
No Significant Effects of Ethyl-Eicosapentanoic Acid on Histologic Features of Nonalcoholic Steatohepatitis in a Phase 2 Trial
2014
Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study
2015
Prevalence and determinants of fatty liver in normal-weight and overweight young adults. The Cardiovascular Risk in Young Finns Study
2014
Noninvasive diagnosis of nonalcoholic fatty liver disease
2009
Nonalcoholic Fatty Liver Disease and Risk of Future Cardiovascular Events Among Type 2 Diabetic Patients
2005
Comparison of Hepatocellular Carcinoma Patients With Alcoholic Liver Disease and Nonalcoholic Steatohepatitis
2004
Nonalcoholic Fatty Liver Disease
2015 Standout
Screening for non‐alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography
2018
Physical Activity and Low Glycemic Index Mediterranean Diet: Main and Modification Effects on NAFLD Score. Results from a Randomized Clinical Trial
2020
Influence of Metabolic Syndrome, Viral Genotype and Antiviral Therapy on Superimposed Fatty Liver Disease in Chronic Hepatitis C
2005
A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease
2017
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Natural history of chronic hepatitis C
2002
From NAFLD to MAFLD: Implications of a Premature Change in Terminology
2020
Works of Terry Gramlich being referenced
Agreement in Pathologic Interpretation of Liver Biopsy Specimens in Posttransplant Hepatitis C Infection
1999
Mushroom poisoning-from diarrhea to liver transplantation
2001
Nonalcoholic fatty liver disease in patients with type 2 diabetes
2004
INTERFERON?? 2B AND RIBAVIRIN IN SEVERE RECURRENT CHOLESTATIC HEPATITIS
2001
Chronic hepatitis C and superimposed nonalcoholic fatty liver disease
2001
A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy
2001
Hepatic iron and nonalcoholic fatty liver disease
1999
Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
2008
The utility of radiological imaging in nonalcoholic fatty liver disease
2002 Standout
Risk Factors for Hepatocellular Carcinoma in Patients with Cirrhosis
2004
Autoimmune Enteropathy in a Pediatric Patient: Partial Response to Tacrolimus Therapy
1997
Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.
1998